(Q80464510)
Statements
Cetuximab and irinotecan as third line therapy in patients with advanced colorectal cancer after failure of irinotecan, oxaliplatin and 5-fluorouracil (English)
Dorte Nielsen
Mette Yilmaz
Anja Iversen
Christian Vejlø
Benny Vittrup Jensen